Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 83.49
+0.99 (1.20%)
Jan 22, 2026, 9:46 AM GMT
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 31.15 million as of January 22, 2026. Its market cap has increased by 41.03% in one year.
Market Cap
31.15M
Enterprise Value
29.44M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
83.49
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 31.15M, a decrease of -53.50%. That is a compound annual growth rate of -15.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 31.15M | 2.48% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | 66.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.42B |
| GSK plc | 72.86B |
| Haleon | 32.16B |
| Smith & Nephew | 10.28B |
| Convatec Group | 4.51B |
| Hikma Pharmaceuticals | 3.42B |
| HUTCHMED (China) | 2.00B |
| Genus | 1.90B |